Arcarios Overview

  • Founded
  • 2010

Founded
  • Status
  • Out of Business

  • Employees
  • 5

Employees
  • Latest Deal Type
  • Out of Business

Arcarios General Information

Description

Provider of drug development services intended for the treatment of bones and joint diseases. The company's drug development services dedicated to the discovery and development of innovative products, enabling users to get durable treatments, validated through controlled clinical trials for damaged and diseased skeletal tissues.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Primary Office
  • Dr. Molewaterplein 40
  • Rotterdam
  • Netherlands

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arcarios Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Nov-2016 00.000 Completed Out of Business
3. Grant 16-Nov-2011 00.000 00.000 Completed Generating Revenue
2. Secondary Transaction - Private $5.31M Completed Generating Revenue
1. Seed Round 25-Aug-2010 $5.31M $5.31M Completed Generating Revenue
To view Arcarios’s complete valuation and funding history, request access »

Arcarios Patents

Arcarios Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2792961-A1 Substituted cyclodextrin derivatives useful as intermediates for producing biologically active materials Inactive 24-Mar-2010 00000000000
EP-2550299-A2 Substituted cyclodextrin derivatives and process for their preparation Inactive 24-Mar-2010 00000000000
US-20130046087-A1 Substituted cyclodextrin derivatives useful as intermediates for producing biologically active materials Inactive 24-Mar-2010 00000000000
CA-2738018-A1 Carboxyethylated cyclodextrin polysulfates useful as medicaments Inactive 22-Sep-2008 00000000000
EP-2331581-A1 Carboxyethylated cyclodextrin polysulfates useful as medicaments Inactive 22-Sep-2008 C08B37/0012
To view Arcarios’s complete patent history, request access »

Arcarios Executive Team (5)

Name Title Board Seat Contact Info
Hans van Leeuwen Ph.D Founder
Gert Wilde Head, Discovery
You’re viewing 2 of 5 executive team members. Get the full list »

Arcarios Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arcarios Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 25-Aug-2010 000000 00 Biotechnology 0000000 0
To view Arcarios’s complete acquisitions history, request access »